by admin | Sep 12, 2022 | News & Opinions
Moderna is suing Pfizer and BioNTech, alleging they copied technology that Moderna first developed years before the pandemic in producing the first COVID-19 vaccine approved in the U.S., the company announced Friday. Driving the news: Moderna is seeking unspecified...
by admin | Sep 11, 2022 | News & Opinions
By Sarah Collins and Jacqueline Garget – University of Cambridge Researchers from the University of Cambridge have created model embryos from mouse stem cells that form a brain, a beating heart, and the foundations of all the other organs of the body – a new...
by admin | Sep 6, 2022 | News & Opinions
Breaking News in #maculardegeneration! First time in USA! Commencement of a Phase 1/2a clinical safety trial using #IPSC stem cells to treat for advanced dry age-related macular degeneration. NIH and #JohnHopkins surgical team implanted a patch of tissue made from...
by admin | Jul 26, 2022 | News & Opinions
By Max Bayer – Fierce Biotech Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday...
by admin | Jun 9, 2022 | News & Opinions, Video, Video Chats
On June 9 at 7:00 PM EDT, Regenerative Medicine Foundation (RMF) broadcast the Stem Cell and Regenerative Medicine Action Awards as part of the combined virtual 17th annual World Stem Cell Summit (WSCS) and Wake Forest Institute for Regenerative Medicine and RMF’s...
